Medical mistrust influences black women's level of engagement in BRCA1/2 genetic counseling and testing

Journal of the National Medical Association

Volumn 105, Issue 1, 2013, Pages 17-22

  Sheppard, Vanessa B ^a   Mays, Darren ^a   La Veist, Thomas ^b   Tercyak, Kenneth P ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

African Americans; Breast cancer; Genetics; Medical mistrust

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; FEMALE; FIRST DEGREE RELATIVE; GENE MUTATION; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; NEGRO; OVARY CANCER; PRIORITY JOURNAL; SECOND DEGREE RELATIVE; SOCIAL CLASS; AFRICAN AMERICAN; BREAST TUMOR; COMPARATIVE STUDY; DOCTOR PATIENT RELATION; ETHICS; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MEDICAL ETHICS; METHODOLOGY; MIDDLE AGED; MUTATION; OVARY TUMOR; PSYCHOLOGICAL ASPECT; RISK FACTOR;

ADULT; AFRICAN AMERICANS; BRCA1 PROTEIN; BREAST NEOPLASMS; ETHICS, PROFESSIONAL; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PHYSICIAN-PATIENT RELATIONS; RISK FACTORS;

MLCS; MLOWN;

EID: 84880832939     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30081-X     Document Type: Article

References (28)

1. Holt K. It does matter: breast cancer is the second leading cause of cancer deaths in American women. American Cancer Society, 2008. Assuming an average life span of 85 years, one in eight US women will be diagnosed with breast cancer. Nurs Womens Health. 2010;14:34-41.
2. Yang X, Lippman ME. BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat. 1999;54:1-10.
3. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
4. Fletcher O, Houlston RS. Architecture of inherited susceptibility to common cancer. Nat Rev Cancer. 2010;10:353-361.
5. Amir E, Freedman OC, Seruga B, et al. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102:680-691.
6. Armstrong K, Micco E, Carney A, et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA. 2005;293:1729-1736.
7. Gao Q, Neuhausen S, Cummings S, et al. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet. 1997;60:1233-1236.
8. Gao Q, Tomlinson G, Das S, et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet. 2000;107(2):186-191.
9. Easton J. Genetic testing for breast cancer could benefit minorities but is underused. www.eurekalert.org/pub-releases/2005-10/uocm-gtf101305. php#. Accessed December 10, 2007.
10. Hall M, Olopade OI. Confronting genetic testing disparities: knowledge is power. JAMA 2005;293(14):1783-1785.
11. Freeman H, Chu K. Determinants of Cancer Disparities: Barriers to Cancer Screening, Diagnosis, and Treatment. Surg Oncol Clin N Am. 2005;655-669.
12. Gerend MA, Pai M. Social determinants of Black-White disparities in breast cancer mortality: a review. Cancer Epidemiol Biomarkers Prev. 2008;17:2913-2923.
13. Forman AD, Hall MJ. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer. Breast J. 2009;15(suppl):S56-S62.
14. Thompson HS, Valdimarsdottir HB, Jandorf L, et al. Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women. Patient Educ Couns. 2003;51:217-227.
15. Federal Financial Institutions Examination Council. (FFIEC) Geocoding system. www.ffiec.gov/geocode/default.aspx. Accessed August 25, 2010.
16. La Veist TA, Isaac LA, Williams KP. Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res. 2009;44:2093-2105.
17. Honey K. GINA: making it safe to know what's in your genes. J Clin Invest. 2008;118:2369.
18. Hughes C, Lerman C, Schwartz M, et al. All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002;107:143-150.
19. Samphao S, Wheeler AJ, Rafferty E, et al. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg. 2009;198:538-543.
20. Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C. Breast cancer genetics in African Americans. Cancer. 2003;97(1 suppl):236-245.
21. Kinney AY, Croyle RT, Dudley WN, Bailey CA, Pelias MK, Neuhausen SL. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med. 2001;33:543-551.
22. Lillie-Blanton M, Brodie M, Rowland D, Altman D, McIntosh M. Race, ethnicity, and the health care system: public perceptions and experiences. Med Care Res Rev. 2000;57(suppl) 1:218-235.
23. Sorkin DH, Ngo-Metzger Q, Alba I. Racial/Ethnic discrimination in health care: impact on preceived quality of care. J Gen Intern Med. 2010;25:390-396.
24. Design Considerations for a Potential United States Population-Based Cohort to Determine the Relationships among Genes, Environment, and Health: Recommendations of an Expert Panel. www.genome.gov/Pages/About/OD/ ReportsPublications/PotentialUSCohort.pdf. Accessed Match 21, 2011.
25. Vadaparampil ST, Quinn GP, Gjyshi A, et al. Development of a brochure for increasing awareness of inherited breast cancer in black women. Genet Test Mol Biomarkers. 2011;15:59-67.
26. Williams J, Wyatt GE, Wingood G. The four C's of HIV prevention with african Americans: crisis, condoms, culture, and community. Curr HIV/AIDS Report. 2010;7:185-193.
27. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995;56:265-271.
28. McBride CM, Bowen D, Brody LC, et al. Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med. 2010;38:556-565.